CS logo
small CS logo
Umhat Kaspela

Plovdiv, Bulgaria
Университетска болница в Пловдив

About Umhat Kaspela


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Janssen Research & Development, LLC
3
Pfizer
2
Gedeon Richter Plc.
1
Gilead Sciences
1
KBP Biosciences
1
Total Rows: 5

Clinical Trials at Umhat Kaspela


During the past decade, Umhat Kaspela conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 3 clinical trials were completed, i.e. on average, 37.5% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 1 clinical trials were completed. i.e. 20% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years330000000055000011111100Started TrialsCompleted Trails2016201720182019202020210246
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Study of the Analgesic Efficacy and Safety of Subcutaneous Tanezumab in Subjects With Osteoarthritis of the Hip or Knee.
2016-03-02
2018-11-14
Completed
849
Safety, Tolerability, and Efficacy of GS-9876 in Participants With Active Rheumatoid Arthritis on Background Therapy With Methotrexate
2016-09-21
2017-09-20
Completed
83
Safety and Efficacy of Pf-06650833 In Subjects With Rheumatoid Arthritis, With An Inadequate Response To Methotrexate
2016-11-10
2018-08-15
Completed
269
A Study of Guselkumab in Participants With Active Psoriatic Arthritis
2021-06-17
2027-12-08
Recruiting
950
A Study of Guselkumab Administered Subcutaneously in Bio-naive Participants With Active Psoriatic Arthritis Axial Disease
2021-08-30
2026-02-13
Recruiting
405
Guselkumab in Active Psoriatic Arthritis Participants With Inadequate Response/Intolerance to One Prior Anti-TNF Alpha Agent
2021-09-28
2026-09-07
Recruiting
450
Efficacy and Safety of KBP-5074 in Uncontrolled Hypertension and Moderate or Severe CKD
2021-11-05
2025-01-22
Recruiting
600
Comparative Efficacy and Safety Study of RGB-14-P and Prolia® in Women With Postmenopausal Osteoporosis
2021-09-21
2023-11-15
Active, not recruiting
473

Rows per page:

1–8 of 8

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Umhat Kaspela" #1 sponsor was "Janssen Research & Development, LLC" with 3 trials, followed by "Pfizer" with 2 trials sponsored, "Gedeon Richter Plc." with 1 trials sponsored, "Gilead Sciences" with 1 trials sponsored and "KBP Biosciences" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Umhat Kaspela" #1 collaborator was "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.
Created with Highcharts 11.1.0Top Leading SponsorsJanssen Research &Development, LLC: 3Janssen Research &Development, LLC: 3Pfizer: 2Pfizer: 2Gedeon Richter Plc.: 1Gedeon Richter Plc.: 1Gilead Sciences: 1Gilead Sciences: 1KBP Biosciences: 1KBP Biosciences: 1

Created with Highcharts 11.1.0Top CollaboratorsEli Lilly and Company: 1Eli Lilly and Company: 1

Clinical Trials Conditions at Umhat Kaspela


According to Clinical.Site data, the most researched conditions in "Umhat Kaspela" are "Arthritis, Psoriatic" (3 trials), "Rheumatoid Arthritis" (2 trials), "Chronic Kidney Diseases" (1 trials), "Osteoarthritis, Hip" (1 trials) and "Osteoarthritis, Knee" (1 trials). Many other conditions were trialed in "Umhat Kaspela" in a lesser frequency.

Clinical Trials Intervention Types at Umhat Kaspela


Most popular intervention types in "Umhat Kaspela" are "Drug" (8 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (6 trials), "Guselkumab" (3 trials), "Filgotinib" (1 trials), "Filgotinib placebo" (1 trials) and "GS-9876" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Umhat Kaspela


The vast majority of trials in "Umhat Kaspela" are 7 trials for "All" genders and 1 trials for "Female" genders.

Clinical Trials Status at Umhat Kaspela


Currently, there are NaN active trials in "Umhat Kaspela". undefined are not yet recruiting, 4 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Umhat Kaspela, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Umhat Kaspela, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 5Phase 3: 5Phase 2: 2Phase 2: 2Phase 4: 1Phase 4: 1

Created with Highcharts 11.1.0Trials StatusRecruiting: 4Recruiting: 4Completed: 3Completed: 3Active, not recruiting: 1Active, not recruiting: 1